Prosight Management »

TrueBlue shares owned by Prosight Management

Quarter-by-quarter ownership of TrueBlue (TBI) shares owned by Prosight Management from 13F filings

Historical chart of Prosight Management investment in TrueBlue

Tip: Access up to 7 years of quarterly data

All positions including TrueBlue held by Prosight Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in TrueBlue by Prosight Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.0M 443k 4.55
2025-09-30 $487k 80k 6.13

More positions owned by Prosight Management

Procept Biorobotics Corp (PRCT)
Galapagos Nv Spon Adr (GLPG)
Janux Therapeutics (JANX)
Adc Therapeutics Sa SHS (ADCT)
Kura Oncology (KURA)
Meiragtx Holdings (MGTX)
Nektar Therapeutics Com New (NKTR)
Veeva Sys Cl A Com (VEEV)
Icon SHS (ICLR)
Boston Scientific Corporation (BSX)
Concentra Group Holdings Par Common Stock (CON)
Phreesia (PHR)
Amicus Therapeutics (FOLD)
Select Medical Holdings Corporation (SEM)
Syndax Pharmaceuticals (SNDX)

View all positions for Prosight Management

Top funds holding TrueBlue

Pzena Investment Management
Robeco Investment Management
BlackRock
Charles Schwab Investment Management
Invesco
Royce & Associates
Vanguard Group
Hotchkis and Wiley Capital Management
Dimensional Fund Advisors
D. E. Shaw & Co
Azarias Capital Management
Geode Capital Management
State Street Corporation
Russell Investments
Nuveen

View all funds holding TrueBlue